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Objectives: to determine graft patency, limb salvage, and patient survival following infrainguinal bypass grafting in
patients with end-stage renal disease (ESRD).
Methods: studies published from 1987 through 2000 were identified from the PUBMED database and pertinent original
articles. Sixteen studies were found that used survival analysis to report the outcomes of interest. Two investigators
independently extracted the data from standard life-tables, survival curves and texts. A new method was developed for
meta-analysis of uncontrolled studies that use survival analysis with different follow-up intervals.
Results: random-effects modelling yielded the following summary estimates at one- and two-year follow-up: 79% (95%
CI, 70–87%) and 74% (63–85%) for graft patency; 77% (69–84%) and 73% (64–81%) for limb salvage; and 59% and
42% for patient survival.
Conclusion: despite a severely limited life span, infrainguinal bypass grafting for the treatment of critical ischaemia is
worthwhile in selected patients with ESRD.
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Introduction calcification.2–8 However, such accelerated arterial dis-
ease combined with impaired immunity, susceptibility
Since diabetes mellitus and high blood pressure are risk to infection, and poor wound healing adversely affect
factors common to renal failure and peripheral arterial surgical outcomes.2,6,7,9–11 Although early graft patency
disease, it is not surprising that some patients with end- rates are satisfactory, arterial reconstruction in the pres-
stage renal disease (ESRD) also develop critical limb ence of ESRD is associated with higher rates of early
ischaemia. The negative impact of the latter condition, amputation and poorer long-term survival.2,5,7,8,10 In such
which is similar to that of advanced cancer,1 further an adverse scenario, it is useful, for patient information
aggravates the already poor functional status of patients and surgical decision-making, to estimate the above
on long-term dialysis. As a consequence, arterial re- outcomes as accurately as possible.
construction or primary amputation must be considered However, only a few studies of small to moderate
for these patients, most of whom typically present wide- size have dealt with infrainguinal bypass grafting in
spread arterial disease, extensive occlusion in the infra- patients with ESRD. In these studies, cumulative success
genicular arteries and a high degree of arterial rates at two-year follow-up have ranged from 47–86%
for graft patency, 35–91% for foot salvage, and 0–100%
for patient survival.3,5,6,12–15 Because of this wide vari-∗ Please address all correspondence to: M. Albers, Rua Ministro
Godo´i, 1584, AP 74, ZIP 05015-001 Sa˜o Paulo, Brazil. ability and the opposing view that primary amputation
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Table 1. Covariates at study level in 16 studies included in theshould be done more frequently,3,10,16 the present meta-
meta-analysis.analysis was done to obtain more precise estimates for
Median Range Missingthe above outcomes in this high risk population.
information
Number of patients 23.5 10–52
Number of procedures 32.5 11–69
Methods Publication year 1995 1988–2000
Years of patient 6.5 4–15
inclusionStudy search Mean age 58.5 45–67 2
Women % 42 18–56 3
Diabetes % 73 55–100 1An electronic search of the PUBMED database covering
Heart disease % 55 18–82 4January 1, 1987 to September 15, 2000 was done using Smokers % 41 15–74 4
the descriptors “end-stage renal disease” and “by- Claudication % 0 0–7 1
Rest pain % 16 0–30 3pass”. Of a total of 195 references retrieved, 14 studies
Tissue loss % 80 57–100 3were initially selected.2–6,8,10,12–14,17–20 Two additional Infrainguinal bypass % 100 79–100
studies were identified by other means. One of these Infrapopliteal bypass % 71 0–100 4
Bypasses/year 5 1–9.5had been cited frequently in the pertinent literature,
Vein usage % 88 48–100 2while the other was identified by pure chance.7,15 There- Follow-up intervals 7 1–24
fore, a total of 16 studies were finally reviewed.
combined to text information supplied a highly plaus-
Criteria for inclusion ible life-table for foot salvage.7 Survival curves also
showing the numbers of units at risk for most intervals
The results of arterial reconstructive surgery in patients were used in five studies thus allowing reliable re-
with ESRD had to be presented separately. A survival construction of the original life-tables. In another study
analysis describing the success rates for at least one using survival curves, the numbers at risk were not
year was also required. The accepted sources of in- shown for all intervals and the information retrieved
formation included standard life-tables, related curves was thus only an approximation.19 The distances be-
showing numbers of units at risk, at least for some tween points on survival curves relative to the x-axis
intervals, individual patient information, and sparse and the y-axis were measured independently by two
estimates of graft patency and the corresponding authors (RLAF and MS) and any discrepancies were
standard-errors. In all cases, these sources should allow resolved in discussion with the senior author (MA).
for the approximate reconstruction of the original life- Finally, individual patients in one study and text in-
tables.21 formation in the remaining study were used as the
In the individual studies, the expression ESRD was source of data.
mostly applied to patients who were dialysis-de- Only one study reported patient survival in a stand-
pendent or had a functioning kidney transplant. How- ard life-table. Survival curves were used in six studies,
ever, in three reports such expression also designated of which three appropriately showed numbers at risk
abnormally higher serum creatinine in patients not yet and three did not. Sparse information regarding some
requiring renal replacement therapy. Two of these point estimates was used in six instances. One study
reports were excluded because most patients were in described the outcome of individual patients and text
such a situation.11,22 The third report, which described information was available in the remaining study. The
only a few such patients, all of whom had serum main features of the 16 studies are summarised in Table
creatinine above 500 mol/l, was included in the re- 1. Follow-up techniques included Duplex-scanning in
view.14 11 studies, were restricted to measurements of seg-
mental blood pressures in four studies, and were not
mentioned in the remaining study.
Data extraction
Life-tables describing graft patency were available in Statistical methods
eight studies, of which only one failed to include
information regarding foot salvage. In this particular Since no method was available for the meta-analysis
of uncontrolled studies that use survival analysis withstudy, a life-table showing secondary graft patency
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different follow-up intervals, a strategy was developed
to combine results across studies. In the first step,
units of analysis leaving the study at intervals of
two or more months were redistributed to one-month
intervals. Simple division redistributed censored units
whereas uncensored units were reallocated under the
assumption of a constant interval failure rate. Al-
though a fractional number was frequently obtained
for the number of failures and withdrawals in each
















Studies in order of publication
life-tables and thus allowed for the pooling of results
Fig. 1. One-year secondary graft patency for 16 studies (circles)at any desired point in time.
and the corresponding summary measure using random-effectsFor each study i and each month j of follow-up, an
modelling (square). Bars indicate the 95% confidence intervals.
interval success rate, ij, was calculated. For the follow-
up interval from zero to three months, Kaplan–Meier
estimates of survival, Li(1,3), were the product i1.i2.i3.
The within-study variance, vi(1,3), as well as the be- salvage rate correlated poorly with publication year
(n=16, r=−0.39), type of renal replacement therapytween-study variance, (1,3)2, was calculated for Li(1,3).24
(n=16, r=−0.02), diabetes mellitus (n=14, r=−0.30),Random-effects modelling yielded a summary
heart disease (n=12, r=0.10), hypertension (n=12,measure of the treatment effect, L(1,3).25 This was done
r=0.35), history of smoking (n=12, r=0.13), type ofby weighing Li(1,3) with wi(1,3), which is the inverse of
graft (n=14, r=0.52), and site of distal anastomosisthe total variance, vi(1,3)+(1,3)2. Next, the entire pro-
(n=12, r=0.49). Because of extensive missing in-cedure was repeated to obtain L(4,12), which was the
formation and the lack of a strong correlation betweenproduct of successive terms i4, i5,..., i12. Similarly,
any covariate and foot salvage at study-level, sec-L(13,20) and L(21,24) were also obtained. For simplicity,
ondary analysis of single studies was kept simple andL(1,3) as the common estimate for cumulative survival
restricted to publication year.at three months may also be written as G3.
The product G3.L(4,12) was used to obtain the common
estimate for cumulative survival at 12-month follow-
up, G12. Similarly, the product G12.L(13,20) yielded G21,
and the product G21.L(21,24) yielded G24. Such estimators ResultsGj will be consistent and approximately normal, and
are derived based on the fact that the estimators
Graft patencyfor each study are approximately normal with an
estimable variance.
The pooled estimate for graft patency was 89% (95%Finally, 95% confidence intervals were constructed
CI: 83–95%) at three months, 79% (70–87%) at 1 year,for G3, G12 and G24 by using the wi3, wi12 and wi24, and 74% (63–85%) at 2 years of follow-up. Figure 1
respectively. The Appendix shows the statistical for- shows the one-year graft patencies in single studies
mulae used. and the corresponding summary measure. The cor-
In the meta-analysis of patient survival, average rection of secondary graft patencies in four studies
estimates were calculated, because most single studies that reported only primary patencies increased the
failed to describe this outcome in sufficient detail. summary one-year graft patency from 79 to 80%.
Sensitivity analyses included cumulative meta-ana- Finally, the eight more recent studies showed a lower
lysis and assessment of publication bias. Such analyses average estimate than the eight oldest studies (67 vs
were restricted to foot salvage because this outcome 81%).
is clinically more relevant than graft patency and
does not depend on the type of patency reported.
Cumulative meta-analysis included one study each
time in the review, according to publication year, while
a funnel graph plotted the one-year cumulated success Foot salvage
rate in single studies against the corresponding sample
size to assess publication bias.26 The pooled estimate for foot salvage at three months,
one year, and two years of follow-up was 85% (95%In the set of 16 single studies, the one-year foot
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Studies in order of publication Fig. 4. A modified funnel graph revealed an asymmetry for study
size less than 20 that suggested some publication bias. When two
Fig. 2. One-year foot salvage for 16 studies (circles) and the cor- fictional studies of small size and poor results (open circles) were
responding summary measure using random-effects modelling added to the 16 published studies (full circles), the average estimate
(square). Bars indicate the 95% confidence intervals. decreased from 74% (solid vertical line) to 72% (dotted vertical line).
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Fig. 5. One-year patient survival for 16 studies (circles) and theFig. 3. Cumulative random-effects meta-analysis included studies
corresponding summary measure using random-effects modellingstepwise according to their year of publication. Bars indicate the
(square).95% confidence intervals.
three months, 2% at one and two years. The eight
CI, 81–90%), 77% (69–84%), and 73% (64–81%), re- more recent studies showed a lower average estimate
spectively. Figure 2 shows foot salvage estimates in for foot salvage than the eight oldest studies (69 vs
single studies and the corresponding summary meas- 79%).
ure for the one-year follow-up.
The first published series of 25 bypasses described
a one-year foot salvage rate of 76% (95% CI, 49–100%). Patient survival
When other seven studies were included in a cumu-
lative meta-analysis, the number of bypasses increased The pooled estimates for patient survival at three
to 288 and the one-year summary estimate of foot months, one year, and two years were 81, 59 and 42%,
salvage was 82% (72–92%). Inclusion of all the studies respectively. Since this analysis used only average
yielded the final result of 77% (69–84%) (Fig. 3). estimates, confidence intervals could not be calculated.
A small degree of publication bias was detected, Figure 5 shows the one-year patient survival in single
but when this was arbitrarily adjusted by adding two studies and the corresponding summary measure. The
small fictional studies with the poorest results, the one-year average estimate of patient survival was
average of the Kaplan–Meier estimates for the one- similar when the eight more recent and the eight oldest
year foot salvage decreased from 74 to 72% (Fig. 4). studies were compared (61 vs 62%).
This empirical procedure was similar to the “trim and
fill” method of evaluating publication bias on meta-
analyses of controlled trials.27 Discussion
Summary point estimates were lower for foot sal-
vage than graft patency during the entire follow-up The enormous potential for bias represents a major
problem in the meta-analysis of uncontrolled studiesperiod, and the corresponding difference was 4% at
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in general and surgical series in particular. In such a trend for decreasing point estimates (Fig. 3). The other
sensitivity analyses yielded unimpressive results.situation, careful appraisal of the methods, clinical
Despite the clinical heterogeneity across the studies,judgement, and common sense are required and feas-
there was no coherent and explicable correlation ofibility is not always assured.26,28–30 However, the present
any covariate at study-level with one-year graft pat-meta-analysis was judged to be meaningful because
ency and foot salvage. Possibly, ESRD exerts such athe reviewed studies clearly presented several fa-
powerful influence on these outcomes that the effectsvourable features such as a specific clinical problem,
of different modelling strategies, minor faults in de-the existence of a population to which conclusions can
sign, and unbalanced covariates become unimportant.be generalised, three well-defined research questions,
However, the comparison of the eight most recentand similar designs. On statistical grounds, these art-
studies with the older studies revealed, perhaps moreicles described high response rates in sufficient detail,
realistically, worse results for graft patency and footat least for graft patency and foot salvage, and also
salvage.allowed several sensitivity analyses and an assessment
Even when different sources of bias and the sub-of publication bias to be made.
group of more recent studies were considered, theAlthough they had only a minor impact on the
one-year summary measure for foot salvage remainedresults, some methodological drawbacks included a
above 65%. This was an important result, since infollow-up shorter than two years in three studies,
patients without ESRD the foot salvage rate mustthe lack of reporting secondary graft patencies in six
exceed 44% to justify infrainguinal bypass, at least instudies, the approximate reconstruction of original
terms of walking ability and quality of life.1 Althoughlife-tables from survival curves or texts in half the
graft patency and foot salvage may improve furtherstudies, the need to redistribute units of analysis to
with the use of pedal branch arteries and perigeniculatemonthly intervals, and poor information on patient
arteries as recipient vessels for bypass,14,31,32 the clinicalsurvival. Standard statistical methods were used and
benefits are limited by poor patient survival. Althoughthe resulting procedure was easy to apply and may
it would have been useful to assess actual palliation,be useful in other similar situations.
which implies an alive patient and a salvaged foot,Most series of infrainguinal bypass grafting in
the pertinent data available in only three small studiespatients without ESRD describe foot salvage rates far
were insufficient to allow this assessment. Unusuallyexceeding graft patency rates. In contrast, a typical
high rates of primary amputation ranging 20–44%finding in the reviewed studies was early major am-
clearly suggest how selected are patients with ESRDputation of a limb in which a patent bypass was
who undergo infrainguinal bypass grafting.4,7,10,16insufficient to heal complex ischaemic or infected skin This meta-analysis confirmed that poor survival is
lesions.5,7,8,10,18 Such problem was reflected in this meta- of most concern for patients with ESRD and severe
analysis since the difference between the summary limb ischaemia, but it also showed that infrainguinal
measures of graft patency and foot salvage reached arterial reconstruction is worthwhile for carefully se-
4% at three months of follow-up. Beyond this time, lected such patients.
however, the difference in favour of graft patency
decreased to 2% at 24 months. Such a trend was
possibly the result of asymptomatic late graft failure
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Appendix Variances
Interval survival For each t, the within-study variance, vit, was obtained
as follows:21
For each study i and each month j of follow-up, a
monthly survival rate, ij, was determined as follows:
vit=Lit2(1−Lit)/nit,
ij=1−fij/nij,
whereas the between-study variance, t2, was cal-where fij is the number of failures and nij is the number culated as follows:
of units (grafts or feet) at risk.
Several intervals t(x,y) may be considered provided
that 1Ζx<yΖj. For convenience, this study used t(1,3), t2=(Lit−mt)2/(kt−1),
t(4,12), t(13,20) and t(21,24). Wherever possible, t(x,y) will be
written simply as t.
Within any given interval t, the product of successive where kt and mt are, respectively, the number of in-
dividual studies and the average for Lit.terms ij yields the interval survival rate, Lit.
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Weighting and combining the Lit was also obtained for t(4,12), t(13,20), and t(21,24). Therefore,
the summary estimate of survival at 12-month follow-
Let wit be the weight attributed to each Lit. When using up, G12, is simply the product G3.L(4,12). Similarly, G21
can be obtained from G12 and L(13,20), and G24 from G21the random-effects model, it follows that:
and L(21,24).
wit=1/(vit+t2).
Variance and confidence interval for GtA summary survival estimate, Lt, was obtained for
interval t as follows:
To obtain a variance V{Gt} for Gt, the following formula
was used:Lt=Litwit/wit.
V{Gt}=(1/wit).
Since t(1,3) months is the first follow-up interval,
L(1,3) is also the summary estimate for survival and Confidence intervals for Gt were then easily ob-
tained.may be written simply as G3. As explained before, Lt
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